Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027

Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027

No trades
See on Supercharts

Key terms


Outstanding amount
‪1.03 B‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
1.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−4.13%
Maturity date
Sep 15, 2027
Term to maturity
2 years

About Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027


Sector
Health Technology
Home page
Issue date
Sep 15, 2023
FIGI
BBG019LVCV78
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.